Hirokazu Kadoya

In Vitro Migratory Potential of Rat Quiescent Hepatic Stellate Cells and Its Augmentation by Cell Activation

Kazuo Ikeda, Tomoyuki Wakahara, Yan Qing Wang et al. · Hepatology · 1999 · 171 citations

Life Sciences, Cell Biology, Molecular Biology +16

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Expression of SPARC by activated hepatic stellate cells and its correlation with the stages of fibrogenesis in human chronic hepatitis

Kazuki Nakatani, Shuichi Seki, Norifumi Kawada et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2002 · 53 citations

Medicine, Cell Biology, Pathology +14

Expression of Cellular Prion Protein in Activated Hepatic Stellate Cells

Kazuo Ikeda, Norifumi Kawada, Yan Qing Wang et al. · American Journal Of Pathology · 1998 · 35 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +11